Post-earnings recap
Reported
Wed, Aug 5, 2026
EPS actual
$1.26
EPS est.
$0.96
EPS surprise
+31.66%
1-day move
-8.41%
LivaNova's earnings report showed a strong EPS beat, indicating better-than-expected profitability. However, the stock fell by 8.41%, suggesting investor concerns, possibly related to the lack of revenue details or future guidance. The market reaction reflects uncertainty despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.26 | $1.09 | +31.66% |
| Revenue | — | $381M | — |
No transcript is on record, and the analysis is based solely on numerical results.
LivaNova PLC is a global medical technology company focused on providing innovative solutions in the health care equipment sector. With a market cap of $5 billion, it plays a crucial role in improving patient outcomes through its advanced medical devices and therapies.
Last quarter
In Q1-2026, LivaNova reported an impressive EPS of $0.98, significantly exceeding expectations of $0.72, resulting in a 15.05% stock increase the following day. However, revenue details were not disclosed.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+38.31%
Avg 1-day reaction
+2.33%
Analysts expect LivaNova to maintain its strong performance with an EPS of $1.09 and revenue of $381 million. The company has a history of beating earnings expectations, which could lead to positive market reactions.
Bull case
If LivaNova exceeds the EPS estimate, it could reinforce investor confidence and lead to a significant stock price increase, similar to past performance.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sell-off, especially given the high implied volatility in the options market.
Key metrics to watch
EPS
$1.09Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$381MTotal revenue reflects the company's ability to sell its products and services, which is vital for assessing growth.
The print will turn on these.
Q1
Will LivaNova's EPS exceed the consensus estimate of $1.09?
A beat on EPS could signal strong operational performance and boost investor sentiment.
Q2
What guidance will management provide regarding future revenue growth?
Guidance on revenue will be crucial for understanding the company's growth trajectory and market positioning.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±12.7%
Why consensus could be wrong
The consensus may underestimate LivaNova's ability to leverage recent innovations in its product lines, potentially leading to higher-than-expected revenue growth.
Supporting evidence
LivaNova has consistently beaten EPS estimates in prior quarters, indicating strong operational execution.
The company's focus on expanding its product offerings may drive unexpected revenue growth.
Options pricing suggests a significant move, indicating that the market is anticipating volatility that could favor a positive outcome.
Key risk
If LivaNova's revenue growth exceeds $385 million, it could challenge the current consensus and lead to upward revisions.
Pre-commit to what would confirm each case.
This quarter's performance is under scrutiny as analysts look for continued growth and profitability in a competitive market.
Bull confirmed if
An EPS of $1.12 or higher would confirm the bull case and indicate strong operational performance.
Bear confirmed if
An EPS below $1.06 would confirm the bear case, suggesting potential operational challenges.
What the market is pricing for the move.
Implied Move
±21.07%
Historical Avg
±10.6%
The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.
Options are pricing ±21.1% while LIVN has averaged ±10.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
55.5%
Smart-money positioning from the most recent 13F filings.
Institutional
112.89%
of float
Insider
0.41%
of float
Holders
449
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
7,565,342 sh · $574.4M
13.73%
6.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If LivaNova beats expectations, history suggests a potential stock increase of around 2.92%, confirming the company's strong growth narrative.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management commentary.
Miss
If LivaNova misses expectations, history indicates a potential decline, with past misses leading to significant negative reactions.
The lines on the call that would change the story.
Primecap Management Company
4,168,377 sh · $316.5M
7.57%
-0.9%
FMR, LLC
3,147,068 sh · $239.0M
5.71%
18.0%
Hood River Capital Management LLC
2,565,477 sh · $194.8M
4.66%
303.0%
AQR Capital Management, LLC
2,356,191 sh · $178.9M
4.28%
-5.5%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.